Biorelate helps scientists solving the most difficult biomedical challenges of today. We do this by curating truths from existing knowledge, enabling smarter and faster research & development.
Location: United Kingdom, England, Manchester
Employees: 11-50
Total raised: $7.81M
Founded date: 2014
Investors 1
| Date | Name | Website |
| - | GC Angels | gcangels.u... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 29.11.2022 | Series A | $7.81M | Maven Capi... |
Mentions in press and media 4
| Date | Title | Description |
| 05.09.2024 | Respected pharma data science pioneer Dr Ben Sidders to spearhead Biorelate's next growth phase as Chief Scientific Officer | Ben Sidders * Dr Sidders brings two decades of deep data science experience, honed across multiple therapeutic areas at Pfizer and AstraZeneca * He will build on Biorelate's strong track record of leveraging advanced data science methods to... |
| 29.11.2022 | Biorelate Raises £6.5M in Series A Funding | Biorelate, a Manchester, UK-based biotech company, raised £6.5M in Series A funding. The round was led by Maven Capital Partners and YFM Equity Partners. The funding was raised through YFM’s VCTs, the Maven VCTs and Triple Point Ventures, w... |
| 29.11.2022 | Biorelate closes out £6.5 million to bring billions of new AI-driven insights to biomedical research | AI in drug discovery company Biorelate has closed a £6.5 million series A round co-led by Maven Capital Partners and YFM Equity Partners, with further funds from Manchester Tech Trust angels and Triple Point Ventures. Now equipped with seri... |
| - | Biorelate | “Biorelate” |